CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

CUECue Biopharma, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $25.87 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$187.93M
CountryUSA
RECENT INSIDER TRADES
  • 2026-08-17 · Ray Sumita (Chief Legal Compliance Officer) · SELL
  • 2026-08-17 · Meluzio Michael Vincent (VP, Prin. Accounting Officer) · OTHER
  • 2026-08-17 · Ray Sumita (Chief Legal Compliance Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders52
Shares held5,417,971
Value$53.66M
Percent of shares outstanding74.58%
As of quarter end2026-06-30
RECENT NEWS
  • B.Riley reiterates Cue Biopharma stock rating on allergy data
  • Cue Biopharma, Inc. (CUE) Discusses Positive Phase II Top Line Results for CUE-221 in Chronic Spontaneous Urticaria - Slideshow
  • Cue Biopharma: Initiating 'Buy' Based On CUE-221 Trial Win CSU With Novel Dual MOA
  • Cue Biopharma, Inc. (CUE) Discusses Positive Phase II Top Line Results for CUE-221 in Chronic Spontaneous Urticaria Transcript
  • Cue Biopharma Shares Jump 41.6% Premarket Following Phase 2 Trial Results
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Cue Biopharma, Inc. (CUE) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit